The FDA could authorize Novavax’s COVID vaccine in a matter of weeks. But it may be too late as 75% of U.S. adults are already vaccinated. Read More
Wed. Jun 29th, 2022
The FDA could authorize Novavax’s COVID vaccine in a matter of weeks. But it may be too late as 75% of U.S. adults are already vaccinated. Read More